نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - darunavir ethanolate 325.23mg equivalent to darunavir 300 mg - film coated tablet - 300 mg - active: darunavir ethanolate 325.23mg equivalent to darunavir 300 mg excipient: crospovidone magnesium stearate opadry orange 85f13962 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - topiramate 300mg;   - film coated tablet - 300 mg - active: topiramate 300mg   excipient: carnauba wax lactose monohydrate magnesium stearate microcrystalline cellulose opadry as opadry red ys-1-1759-g sodium starch glycolate starch

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - topiramate 400mg;   - film coated tablet - 400 mg - active: topiramate 400mg   excipient: carnauba wax lactose monohydrate magnesium stearate microcrystalline cellulose opadry white ys-1-7706-g as opadry white ys-1-7706-g sodium starch glycolate starch

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - bortezomib 3.5mg (as a bortezomib mannitol ester that is formed during fp manufacture.) - powder for injection - 3.5 mg - active: bortezomib 3.5mg (as a bortezomib mannitol ester that is formed during fp manufacture.) excipient: mannitol - velcade in combination with melphalan and prednisone, is indicated for the treatment of patients with previously untreated multiple myeloma, who are not suitable for high dose chemotherapy. velcade as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. velcade is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease.

المملكة المتحدة - الإنجليزية - myHealthbox

janssen-cilag ltd - risperidone - tablets - 4 mg - other antipsychotic - it is indicated for the treatment of schizophrenia; for the treatment of moderate to severe manic episodes associated with bipolar disorders; in patients with moderate to severe alzheimer's dementia; forf persistent aggression in conduct disorder in children from the age of 5 years and adolescents with subaverage intellectual functioning or mental retardation

المملكة المتحدة - الإنجليزية - myHealthbox

janssen-cilag ltd - risperidone - tablets - 3 mg - other antipsychotic - it al is used to treat the following: schizophrenia, mania, aggression in people with alzheimer’s dementia, aggression in intellectually disabled children (at least 5 years of age) and adolescents with conduct disorder.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - darunavir ethanolate 867.28mg equivalent to darunavir 800 mg - film coated tablet - 800 mg - active: darunavir ethanolate 867.28mg equivalent to darunavir 800 mg excipient: colloidal silicon dioxide crospovidone hypromellose magnesium stearate opadry red 85f150004 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - itraconazole - oral solution - 10mg/1ml

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - oxybutynin hydrochloride - modified-release tablet - 10mg

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - methylphenidate hydrochloride - modified-release tablet - 18mg